DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2008

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End

31/12/2008
Quarter2
Quarterly report for the financial period ended30/06/2008
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2008
30/06/2007
30/06/2008
30/06/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
33,505
27,699
60,977
55,804
2Profit/(loss) before tax
10,784
10,468
20,630
21,334
3Profit/(loss) for the period
7,980
7,559
15,291
15,492
4Profit/(loss) attributable to ordinary equity holders of the parent
7,980
7,559
15,291
15,492
5Basic earnings/(loss) per share (sen)
5.75
5.45
11.02
11.16
6Proposed/Declared dividend per share (sen)
8.00
14.00
8.00
14.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
0.9300
0.8200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced26 Aug 2008  
CategoryFinancial Results
Reference NoCD-080825-61314